Concepedia

Author

Yinci Zhang

Anhui University of Science and TechnologyORCID

Also Known As

Yinci Zhang

33

Publications

619

Citations

17

H-Index

37

Concepts

All Affiliations

Anhui University of Science and TechnologySecond People’s Hospital of Huai’anXuzhou Medical CollegeFirst Affiliated Hospital of Bengbu Medical CollegeJinan University
YZ

About

Yinci Zhang is an author at Anhui University of Science and Technology specializing in medicine, cell biology, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

228

2

Engineering

2

2

115

3

Biomedical Engineering

2

2

115

4

Health Sciences

1

1

30

5

Biomolecular Engineering

1

1

62

Yinci Zhang

×

20

Publications

597

Citations

17

H-Index

YearCitations

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

Xiaolong Tang, Longzhou Chen, Amin Li,

Drug Delivery

2018

62

Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma

Huaiyong Gan, Longzhou Chen, Xuemei Sui,

Materials Science and Engineering C

2018

53

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li,

PubMed

2019

44

Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals

Yinci Zhang, Jiaojiao Liang, Niandie Cao,

Cell Death Discovery

2022

44

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li,

Toxicology Mechanisms and Methods

2021

40

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu,

International Journal of Medical Sciences

2021

36

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang,

PubMed

2019

32

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway

Ruyue Xu, Yinci Zhang, Amin Li,

Molecular Medicine Reports

2021

30

ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals

Yinci Zhang, Niandie Cao, Jiafeng Gao,

Journal of Cellular and Molecular Medicine

2022

30

ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway

Yinci Zhang, Jiaojiao Liang, Niandie Cao,

BMC Cancer

2022

29

Page 1